Serelaxin is a recombinant form of human relaxin-2, a vasodilator hormone that contributes to cardiovascular and renal adaptations during pregnancy. Previous studies have suggested that treatment with serelaxin may result in relief of symptoms and in better outcomes in patients with acute heart failure.
Effects of serelaxin in patients with acute heart failure
Metra M.Membro del Collaboration Group
;Ferrari R.;
2019-01-01
Abstract
Serelaxin is a recombinant form of human relaxin-2, a vasodilator hormone that contributes to cardiovascular and renal adaptations during pregnancy. Previous studies have suggested that treatment with serelaxin may result in relief of symptoms and in better outcomes in patients with acute heart failure.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
nejmoa1801291.pdf
accesso aperto
Tipologia:
Full Text
Licenza:
PUBBLICO - Pubblico con Copyright
Dimensione
303.9 kB
Formato
Adobe PDF
|
303.9 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
